These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 4805158)

  • 1. In Vivo Optical Imaging of Myelination Events in a Myelin Basic Protein Promoter-Driven Luciferase Transgenic Mouse Model.
    Cao J; Hu Y; Shazeeb MS; Pedraza CE; Pande N; Weinstock D; Polites GH; Zhang W; Chandross KJ; Ying X
    ASN Neuro; 2018; 10():1759091418777329. PubMed ID: 29806482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases.
    Vega-Riquer JM; Mendez-Victoriano G; Morales-Luckie RA; Gonzalez-Perez O
    Curr Neuropharmacol; 2019; 17(2):129-141. PubMed ID: 28714395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination.
    Samanta J; Grund EM; Silva HM; Lafaille JJ; Fishell G; Salzer JL
    Nature; 2015 Oct; 526(7573):448-52. PubMed ID: 26416758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological demyelination triggers macrophage/microglial cells activation without inducing astrogliosis.
    Cloutier F; Sears-Kraxberger I; Keachie K; Keirstead HS
    Clin Dev Immunol; 2013; 2013():812456. PubMed ID: 24319469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.
    Taylor LC; Gilmore W; Matsushima GK
    Brain Pathol; 2009 Jul; 19(3):467-79. PubMed ID: 19016742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the early stages of remyelination following cuprizone-induced demyelination.
    Stidworthy MF; Genoud S; Suter U; Mantei N; Franklin RJ
    Brain Pathol; 2003 Jul; 13(3):329-39. PubMed ID: 12946022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.
    Matsushima GK; Morell P
    Brain Pathol; 2001 Jan; 11(1):107-16. PubMed ID: 11145196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The demonstration of recurrent demyelination and remyelination of axons in the central nervous system.
    Johnson ES; Ludwin SK
    Acta Neuropathol; 1981; 53(2):93-8. PubMed ID: 7211208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological similarities between scrapie and cuprizone toxicity in mice.
    Pattison IH; Jebbett JN
    Nature; 1971 Mar; 230(5289):115-7. PubMed ID: 4101034
    [No Abstract]   [Full Text] [Related]  

  • 10. Variation in the response of mice to cuprizone.
    Elsworth S; Howell JM
    Res Vet Sci; 1973 May; 14(3):385-7. PubMed ID: 4805158
    [No Abstract]   [Full Text] [Related]  

  • 11. Unsuccessful attempts to produce disease with tissues from mice fed on a diet containing cuprizone.
    Pattison IH; Jebbett JN
    Res Vet Sci; 1973 Jan; 14(1):128-30. PubMed ID: 4736048
    [No Abstract]   [Full Text] [Related]  

  • 12. Cuprizone toxicosis in mice--attempts to antidote the toxicity.
    Kesterson JW; Carlton WW
    Toxicol Appl Pharmacol; 1972 May; 22(1):6-13. PubMed ID: 5034989
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and histological recovery from the scrapie-like spongiform encephalopathy produced in mice by feeding them with cuprizone.
    Pattison IH; Jebbett JN
    J Pathol; 1973 Mar; 109(3):245-50. PubMed ID: 4737068
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and histological observations on cuprizone toxicity and scrapie in mice.
    Pattison IH; Jebbett JN
    Res Vet Sci; 1971 Jul; 12(4):378-80. PubMed ID: 5105163
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.